Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Fresh Tracks Therapeutics Inc FRTX

Healthcare Biotechnology
Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.

Recent & Breaking News (GREY:FRTX)

Vical Reports 2013 Financial Results and Progress in Key Development Programs

GlobeNewswire February 12, 2014

Vical to Present at the 2014 Leerink Global Healthcare Conference

GlobeNewswire February 7, 2014

Vical Announces News Release and Conference Call Schedule for 2013 Financial Results

Globe Newswire February 5, 2014

Glu Mobile Adds an Arsenal of New Titles to Give 'Deer Hunter' Company: Glu Mobile Inc. (NASDAQ: GLUU), Aeterna Zentaris Inc. (NASDAQ: AEZS), Vical Inc. (NASDAQ:VICL), Delcath Systems Inc. (NASDAQ: DCTH)

Accesswire January 28, 2014

VICAL INCORPORATED SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Vical Incorporated and Its Board of Directors and a Lead Plaintiff Deadline of December 31, 2013 -- VICL

Marketwired December 24, 2013

Vical Announces Initiation of Phase 1/2 Trial of a Therapeutic HSV-2 Vaccine for Genital Herpes

Globe Newswire December 17, 2013

Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against Vical Incorporated

Business Wire December 13, 2013

SHAREHOLDER ALERT: Pomerantz Law Firm Has Filed a Class Action Against Vical Incorporated and Certain Officers -- VICL

Marketwired December 13, 2013

VICAL INCORPORATED SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Vical Incorporated and Its Board of Directors and a Lead Plaintiff Deadline of December 31, 2013 -- VICL

Globe Newswire December 13, 2013

Astellas and Vical Announce Initiation of Phase 2 Trial of ASP0113, a Cytomegalovirus Vaccine, in Solid Organ Transplant Recipients

PR Newswire December 10, 2013

Law Offices of Howard G. Smith Announces Investigation on Behalf of Investors of Vical Incorporated

Business Wire December 6, 2013

SHAREHOLDER ALERT: Brower Piven Encourages Investors With More Than $100,000 in Losses from Investment in Vical Incorporated to Contact Brower Piven Before the December 31, 2013 Lead Plaintiff Deadline

Business Wire December 5, 2013

SHAREHOLDER ALERT: Pomerantz Law Firm has filed a Class Action Against Vical Incorporated and Certain Officers - VICL

PR Newswire November 27, 2013

Glancy Binkow & Goldberg Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against Vical Incorporated

Business Wire November 22, 2013

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Vical Incorporated of Class Action Lawsuit and Upcoming Deadline -- VICL

Globe Newswire November 19, 2013

Presentation of Vical's Allovectin(R) Phase 3 Results Scheduled at Society for Melanoma Research Meeting

Globe Newswire November 18, 2013

Attention Vical Incorporated Investors: Vical Misled Investors According to a Newly Filed Class Action

PR Newswire November 14, 2013

Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against Vical Incorporated

Business Wire November 12, 2013

SHAREHOLDER ALERT: Brower Piven Encourages Investors With More Than $100,000 in Losses from Investment in Vical Incorporated to Contact Brower Piven Before the December 31, 2013 Lead Plaintiff Deadline

Business Wire November 8, 2013

Harwood Feffer LLP Announces Investigation of Vical Incorporated

PR Newswire November 6, 2013